Overall, the TME quality seems to embody the highest prognostic relevance in HR (hormone receptors)-/HER2- and HER2+ tumors, which contrasts with HR+/HER2- tumors for whom tumor proliferation is the strongest parameter predicting clinical outcomes [6]. This evidence concerns the gene ERBB2 and neoplasm.